35 post-doc-image-engineering-computer-vision Fellowship research jobs at Nature Careers in Uk
-
Full time starting salary is normally in the range £36,636 to £46,049 with potential progression once in post to £48,822 Grade: 7 Full Time, Fixed Term contract up to September 2026 Closing date: 21st
-
to £46,049 with potential progression once in post to £48,822 Grade: 7 Full Time, Fixed Term contract up to January 2029 Closing date: 5th October 2025 Background The Project: World Meteorological Organization
-
to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract for one year with a possibility of an extension for one more year Closing date: 14th September 2025 UK and
-
) does not exceed 7 years. For general information on Postdocs at The ICR, more information can be found here . Department/Directorate Information The Division of Radiotherapy and Imaging brings together
-
post has arisen to work for 2 years (in the first instance) on a Programme grant joint between UCL, Insititute of Child Health and University of Newcastle entitled INSTINCT-MBINSTINCT MB. The work in the
-
Position Details School of Computer Science Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential
-
, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to October 2030 Closing date
-
, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to October 2030 Closing date
-
Background We are seeking a talented and motivated post-doctoral researcher to join Rheumatology Research Group. The Research Fellow will be supervised by Dr John Reynolds and Dr Jason Turner within
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic